Top Markets
Coin of the day
Cardiol Therapeutics Inc. Cardiol Therapeutics Inc.

Cardiol Therapeutics Inc.

CRDL
Rang in aandelen #17186
Cardiol Therapeutics Inc. operates as a clinical-stage life sciences company,... Cardiol Therapeutics Inc. operates as a clinical-stage life sciences company, primarily engaged in the discovery and advancement of treatments designed to combat fibrosis and inflammation within the context of cardiovascular diseases. Its flagship product, CardiolRx, is currently undergoing a significant Phase II/III international clinical trial. This extensive study is randomized, double-blind, and placebo-controlled, evaluating CardiolRx's efficacy and safety as a heart-protective therapy to mitigate cardiovascular and respiratory issues in individuals hospitalized with COVID-19. Concurrently, the trial also assesses CardiolRx's role in addressing acute myocarditis. Beyond this, the company is developing an injectable, subcutaneous formulation of CardiolRx, intended to target cardiac scarring and inflammation that contribute to the development and worsening of heart failure. Established in 2017, Cardiol Therapeutics Inc. is based in Oakville, Canada.
Aandeelprijs
$2.17
Marktkapitalisatie
$249.58M
Verandering (1 dag)
-1.67%
Verandering (1 jaar)
96.34%
Land
CA
Handel Cardiol Therapeutics Inc. (CRDL)

Categorie

Aandelsplitsingen voor Cardiol Therapeutics Inc. (CRDL)
Het aandeel Cardiol Therapeutics Inc. (symbool: CRDL) heeft in totaal 0 splitsingen ondergaan.
De meest recente splitsing vond plaats op Sep 02, 2026.
Eén aandeel CRDL dat vóór Sep 02, 2026 werd gekocht, staat nu gelijk aan 0 aandelen CRDL.
Lijst van aandelen splitsingen
Jaar Splitsing Vermenigvuldiging Cumulatieve vermenigvuldiging
Niet genoeg gegevens voor de verstrekte datums.
Aandelsplitsingen van vergelijkbare bedrijven of concurrenten